Search company, investor...
Q Bio company logo

Q Bio

Founded Year



Series C | Alive

Total Raised


Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+30 points in the past 30 days

About Q Bio

Q Bio builds the clinical digital twin platform. It delivers technology that quantifies, digitizes, and simulates human physiology. The company was founded in 2015 and is based in San Carlos, California.

Headquarters Location

1411 Industrial Road

San Carlos, California, 94070,

United States

Missing: Q Bio's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Q Bio's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Q Bio

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Q Bio in 1 CB Insights research brief, most recently on Dec 23, 2020.

Expert Collections containing Q Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Q Bio is included in 4 Expert Collections, including Digital Health.


Digital Health

10,341 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Biopharma Tech

260 items


Precision Medicine Tech Market Map

160 items

This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.

Q Bio Patents

Q Bio has filed 21 patents.

The 3 most popular patent topics include:

  • Nuclear magnetic resonance
  • Medical imaging
  • Spectroscopy
patents chart

Application Date

Grant Date


Related Topics




Medical tests, Blood tests, Medical testing equipment, Medical terminology, Medical statistics


Application Date


Grant Date



Related Topics

Medical tests, Blood tests, Medical testing equipment, Medical terminology, Medical statistics



Latest Q Bio News

AI Solutions Pioneer Spacee Adds Thiel Capital Managing Director, Former PayPal SVP to Advisory Board

Nov 30, 2022

AI Solutions Pioneer Spacee Adds Thiel Capital Managing Director, Former PayPal SVP to Advisory Board Jack Selby was one of the original employees at PayPal. He later served as a corporate officer/SVP overseeing PayPal's international and corporate operations. Selby says he'll work with Spacee's team to bring its computer vision tech "to more businesses who will be leveraging AI innovation to streamline efficiencies, draw more customers into stores, and ultimately improve their bottom line." Spacee's patented computer vision and AI capabilities can provide near real-time analytical data to help retailers with decision making. [Image: Spacee] Dallas-based Spacee, a provider of computer vision and AI solutions that help businesses drive new insights, improve efficiency, and boost revenue, announced that technology and finance entrepreneur Jack Selby will join its advisory board. Jack Selby Selby is managing director of Thiel Capital, managing partner at AZ-VC, and managing partner at High Frequency Entertainment. Thiel Capital is a California-based investment firm founded by billionaire PayPal co-founder Peter Thiel. Selby was one of the original employees at PayPal. He later served as a corporate officer/senior vice president, overseeing that company’s international and corporate operations. “I’m very impressed with the team at Spacee and how they’re using computer vision technology to address challenges retailers are facing managing inventory and improving supply chain efficiency while creating more interactive in-store environments,” Selby said in a statement. “I’m excited to jump in and work with Skip and team to bring Spacee technology to more businesses who will be leveraging AI innovation to streamline efficiencies, draw more customers into stores, and ultimately improve their bottom line.” Involved with SpaceX, Palantir, Q Bio, and other companies As an active technology investor and advisor, Selby is involved with notable companies such as SpaceX, Palantir, Affirm, Blend, Offerpad, Myeloid Therapeutics, Kisbee Therapeutics, Resonance Medicine, Paradox, Q Bio, Senzo, Halo, Group Nine Media, Wick Communications and others. He’s also on the advisory board of the Dubai Chamber of Digital Economy. Skip Howard, Spacee [Photo: Skyler Fike/Dallas Innovates] “Jack’s experience is invaluable to any technology company,” said Skip Howard, founder and CEO of Spacee. “We’re very fortunate to have Jack as an advisor with his decades of expertise as an entrepreneur working with giants in tech innovation. As we further develop our computer vision solutions and expand our customer footprint, Jack’s guidance and connections within the technology community will be instrumental to Spacee’s growth.” Spacee’s other advisory board members include Brad Anderson, former CEO of Best Buy ; Brad Crutcher, former COO and CEO of Texas Instruments; and Duncan MacFarlane, professor of Electrical Engineering at Southern Methodist University. Spacee pioneered the use of computer vision in retail in 2017, with the first computer vision-driven interactive in-store experiences. In June, it launched Hovertouch, which offers in-store touchscreen-like experiences without a touchscreen in sight. Spacee leverages computer vision AI to create memorable retail experiences, gather actionable real-time analytical data, and increase supply chain efficiency. Get on the list. Dallas Innovates, every day. Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day. One quick signup, and you’re done. In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Exela Technologies, Newmark, OrangeGrid, RailPros, Aimbridge Hospitality, Integrity Marketing Group, Smoothie King, Bank of Texas, MD7, Salvation Army, and more. Plus, you'll find board appointments including Texas Mutual Insurance, Zimperium, and the Ebby Halliday Foundation. It's the first transition of chairs since the organization’s inception. The new chair was announced at the 2022 State of My Possibilities, a virtual event. Plus, Big Thought's Byron Sanders joined My Possibilities' Michael Thomas in a discussion of the importance of creativity and innovation in the charitable sector. Here's a takeaway.

Q Bio Frequently Asked Questions (FAQ)

  • When was Q Bio founded?

    Q Bio was founded in 2015.

  • Where is Q Bio's headquarters?

    Q Bio's headquarters is located at 1411 Industrial Road, San Carlos.

  • What is Q Bio's latest funding round?

    Q Bio's latest funding round is Series C.

  • How much did Q Bio raise?

    Q Bio raised a total of $40M.

  • Who are the investors of Q Bio?

    Investors of Q Bio include Founders Fund, Beast Ventures, SciFi VC, Sea Lane Ventures, Thirty Five Ventures and 6 more.

  • Who are Q Bio's competitors?

    Competitors of Q Bio include Biotwin and 1 more.

Compare Q Bio to Competitors

Prenuvo Logo

Prenuvo is a medical technology company specializing in whole-body medical diagnostic imaging. It specializes in whole-body MRI screening with a track record of early detection of cancer and other major health diseases. The company was founded in 2018 and is based in San Francisco, California. Logo develops a machine learning platform for complex systems using the concept of model integration as a fundamental basis to build artificial intelligence (AI) models. The company is primarily focused on healthcare. Its primary use cases are prostate cancer diagnosis from MRI images, bone fracture diagnosis in emergency care situations from X-rays, and predicting liver disease susceptibility. It was founded in 2019 and is based in London, United Kingdom.

Health Nucleus

Health Nucleus uses whole genome sequencing analysis and advanced digital imaging along with personal biomarkers to deliver a complete picture of individual health. By harnessing 150 gigabytes of health data on each client, it is able to pinpoint pre-symptomatic risks of cardiovascular disease, cancer, neurological disease and degradation, metabolic health status, and more.

Maxwell Plus Logo
Maxwell Plus

Maxwell Plus provides a platform that predicts the risk of prostate cancer in men. It also connects businesses with clinics providing prostate cancer testing through its platform. It was founded in 2016 and is based in Brisbane, Queensland.

Princeton Longevity Center

Princeton Longevity Center is a medical facility. It provides preventive medicine and executive health programs. It was founded in 2001 and is based in Princeton, New Jersey.

LeggUP Logo

LeggUP is a Los Angeles, CA-based professional development platform. LeggUP provides a platform that allows enterprise clients to manage their professional development programs by offering more personalized experiences within their employee benefits packages.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.